Literature DB >> 28533154

Preconception and prenatal genetic counselling.

Adonis S Ioannides1.   

Abstract

Identifying individuals at risk of having children affected by genetic conditions or congenital anomalies allows counselling that aims to inform reproductive decisions. This process takes place either at the preconception or early prenatal stage, although more options are available if risks are identified before the pregnancy. Preconception counselling covers issues that can affect the health of the mother and baby including folic acid supplementation. Carrier screening for autosomal recessive diseases, such as beta thalassaemia, has resulted in a significantly reduced incidence in many countries. National organisations, however, advocate more in-depth research before such screening recommendations apply to the general population. Recently, advances in genomic technologies have made it possible to greatly expand the scope of genetic screening, with the aim of providing more comprehensive information to prospective parents. This is a complex field, and research should focus on how the technology can be put to best use in the future.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  folic acid; genetic counselling; genetic testing; mass screening; preconception care; prenatal care

Mesh:

Year:  2017        PMID: 28533154     DOI: 10.1016/j.bpobgyn.2017.04.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  2 in total

1.  First French study relative to preconception genetic testing: 1500 general population participants' opinion.

Authors:  Maud Jourdain; Bertrand Isidor; Valérie Bonneau; Mathilde Nizon; Xenia Latypova; Aurélie Gaultier; Eugénie Hoarau; Stéphane Bézieau; Guy Minguet; Mauro Turrini
Journal:  Orphanet J Rare Dis       Date:  2021-03-12       Impact factor: 4.123

2.  Clinical utility of combined preimplantation genetic testing methods in couples at risk of passing on beta thalassemia/hemoglobin E disease: A retrospective review from a single center.

Authors:  Chonthicha Satirapod; Matchuporn Sukprasert; Bhakbhoom Panthan; Angkana Charoenyingwattana; Pawares Chitayanan; Wasun Chantratita; Wicharn Choktanasiri; Objoon Trachoo; Suradej Hongeng
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.